All Posts

Donanemab (brand name Kisunla) is a new medicine approved to treat people with early-stage Alzheimer’s disease, specifically those with mild cognitive impairment or mild dementia. It works by helping the body clear amyloid plaques from the brain, which are thought to play a role in Alzheimer’s disease.[1][2] In this blog we will discuss clinical trial TRAILBLAZER-ALZ 2 which studied Donanemab infusions and its benefits and risks in early Alzheimers patients. In this large cli

Five science-backed tips for improving brain health and slowing cognitive decline.

In today's fast-paced world, healthcare is evolving rapidly. One of the most exciting developments is the rise of personalized membership-based practices, especially in neurology. We at Direct Neurology focus on providing tailored care for various neurological disorders. We offer a unique approach that prioritizes the individual needs of our patients. This blog post will explore how our practice work, it's benefits, and what you can expect if you choose to join us for your ne